Fidelity Investments’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3M | Buy |
1,567,010
+576,150
| +58% | +$10.1M | ﹤0.01% | 1591 |
|
|
2025
Q1 | $12.5M | Sell |
990,860
-111,365
| -10% | -$1.4M | ﹤0.01% | 1843 |
|
|
2024
Q4 | $11.6M | Buy |
1,102,225
+15,910
| +1% | +$168K | ﹤0.01% | 1889 |
|
|
2024
Q3 | $15.8M | Buy |
1,086,315
+997
| +0.1% | +$14.5K | ﹤0.01% | 1791 |
|
|
2024
Q2 | $9.24M | Buy |
1,085,318
+396
| +0% | +$3.37K | ﹤0.01% | 1883 |
|
|
2024
Q1 | $11.1M | Sell |
1,084,922
-117,393
| -10% | -$1.2M | ﹤0.01% | 1835 |
|
|
2023
Q4 | $6.59M | Sell |
1,202,315
-105,025
| -8% | -$576K | ﹤0.01% | 1975 |
|
|
2023
Q3 | $4.94M | Sell |
1,307,340
-3,357,438
| -72% | -$12.7M | ﹤0.01% | 2049 |
|
|
2023
Q2 | $31.3M | Sell |
4,664,778
-423,475
| -8% | -$2.84M | ﹤0.01% | 1454 |
|
|
2023
Q1 | $33.1M | Sell |
5,088,253
-281,109
| -5% | -$1.83M | ﹤0.01% | 1409 |
|
|
2022
Q4 | $45.8M | Buy |
5,369,362
+605,813
| +13% | +$5.17M | ﹤0.01% | 1287 |
|
|
2022
Q3 | $25.2M | Buy |
4,763,549
+1,045,097
| +28% | +$5.52M | ﹤0.01% | 1537 |
|
|
2022
Q2 | $15.8M | Sell |
3,718,452
-74,720
| -2% | -$317K | ﹤0.01% | 1754 |
|
|
2022
Q1 | $13.3M | Buy |
3,793,172
+39,435
| +1% | +$138K | ﹤0.01% | 1999 |
|
|
2021
Q4 | $25M | Sell |
3,753,737
-534,812
| -12% | -$3.56M | ﹤0.01% | 1721 |
|
|
2021
Q3 | $42.8M | Sell |
4,288,549
-399,419
| -9% | -$3.99M | ﹤0.01% | 1482 |
|
|
2021
Q2 | $145M | Sell |
4,687,968
-137,591
| -3% | -$4.25M | 0.01% | 952 |
|
|
2021
Q1 | $209M | Buy |
4,825,559
+1,384,255
| +40% | +$59.9M | 0.02% | 771 |
|
|
2020
Q4 | $156M | Buy |
+3,441,304
| New | +$156M | 0.01% | 853 |
|